Iodine Tincture Mild Liquid
FDA Label NDC 0395-1213

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Humco Holding Group, Inc. for the product Iodine Tincture Mild (NDC 0395-1213). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, purpose, indications, warnings, ask a doctor before use if you have, stop use and consult doctor if, when using this product, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredient

Iodine 2%

Sodium Iodide 2.4%

Alcohol 47%

Purpose

First Aid Antiseptic

First Aid Antiseptic

First Aid Antiseptic

Indications

First aid to help prevent infection in minor cuts, scrapes and burns

Warnings

For external use only.

Ask A Doctor Before Use If You Have

  • deep or puncture wounds
  • animal bites
  • serious burns
  • Flammable: Keep away from sparks heat and flame

Stop Use And Consult Doctor If

  • the condition persists or gets worse, or if using for longer than one week

When Using This Product

  • do not use in the eyes. If contact occurs, flush with large amounts of water while lifting upper and lower lids
  • do not apply over large areas of the body

Keep Out Of Reach Of Children.

In case of accidental ingestion, give milk then a starch solution made by mixing two tablespoonfuls of cornstarch or flour to a pint of water. Contact a Poison Control Center immediately.

Directions

  • clean the affected area
  • apply a small amount on the area 1 to 3 times daily
  • may be covered with sterile bandage
  • if bandaged let dry first

Other Information

  • will stain skin and clothing

Inactive Ingredient

Purified Water

* Please review the disclaimer below.